Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis

This publication has 49 references indexed in Scilit:

• Variable presence of KIT^D816V in clonal haematological non‐mast cell lineage diseases associated with systemic mastocytosis (SM–AHNMD)
  The Journal of Pathology, 2009
• Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis
  The American Journal of Pathology, 2009
• Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
  Blood, 2008
• CD30-Induced Signaling Is Absent in Hodgkin's Cells but Present in Anaplastic Large Cell Lymphoma Cells
  The American Journal of Pathology, 2008
• Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
  Leukemia, 2006
• Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease
  British Journal of Haematology, 2001
• CD30 in Normal and Neoplastic Cells
  Clinical Immunology, 1999
• Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
  Journal of Clinical Investigation, 1993
• Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
  Nature, 1982
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981